Filing Details

Accession Number:
0001213900-23-052442
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-28 15:47:14
Reporting Period:
2023-06-26
Accepted Time:
2023-06-28 15:47:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781174 Acrivon Therapeutics Inc. ACRV () G4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590232 Ltd Chione Simou Menardou 5,
Kifisia Court, Office 225
Larnaca G4 6015
No No Yes No
1591256 Andreas Hadjimichael C/O Chione Limited Simou Menardou 5,
Kifisia Court, Office 225
Larnaca G4 6015
No No Yes No
1591274 Wiaczeslaw Smolokowski C/O Chione Limited Simou Menardou 5,
Kifisia Court, Office 225
Larnaca G4 6015
No No Yes No
1591275 Marcin Czernik C/O Chione Limited Simou Menardou 5,
Kifisia Court, Office 225
Larnaca G4 6015
No No Yes No
1954186 Anastasis Nikolaou C/O Chione Limited Simou Menardou 5,
Kifisia Court, Office 225
Larnaca G4 6015
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-26 16 $12.93 3,848,632 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares referred to in Column 4 were sold at $12.925 and $12.93.
  2. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in footnote 1 above.
  3. Shares owned directly by Chione Limited ("Chione"). Chione's directors, Marcin Czernik, Andreas Hadjimichael and Anastasis Nikolaou, and its sole shareholder, Wiaczeslaw Smolokowski, may be deemed to share beneficial ownership of the shares directly owned by Chione.
  4. Each reporting person states that neither the filing of this Form 4 nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or otherwise, the beneficial owner of any securities covered by this Form 4. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.
  5. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this Form 4 nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.